528201 Sigma-AldrichPNU-120596 - CAS 501925-31-1 - Calbiochem
A urea derivative that acts as a potent, selective, and reversible positive allosteric modulator for the α7 subtype of neural nicotinic acetylcholine receptors
More>> A urea derivative that acts as a potent, selective, and reversible positive allosteric modulator for the α7 subtype of neural nicotinic acetylcholine receptors Less<<Synonymes: α7 Neuronal Nicotinic Acetylcholine Receptor Agonist, PNU-120596, 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea, a7 nAChR agonist, PNU-120596
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
CAS # | Empirical Formula |
---|---|
501925-31-1 | C₁₃H₁₄ClN₃O₄ |
Prix & Disponibilité
Référence | Disponibilité | Conditionnement | Qté | Prix | Quantité | |
---|---|---|---|---|---|---|
528201-10MG |
|
Flacon en verre | 10 mg |
|
— |
References | |
---|---|
References | Hurst, R., et al. 2005. J. Neurosci. 25, 4396. Barron, S., et al. 2009. Mol. Pharm. 76, 253. |
Product Information | |
---|---|
CAS number | 501925-31-1 |
Form | White solid |
Hill Formula | C₁₃H₁₄ClN₃O₄ |
Chemical formula | C₁₃H₁₄ClN₃O₄ |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥99% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Référence | GTIN |
528201-10MG | 04055977196474 |
Documentation
PNU-120596 - CAS 501925-31-1 - Calbiochem FDS
Titre |
---|
PNU-120596 - CAS 501925-31-1 - Calbiochem Certificats d'analyse
Titre | Numéro de lot |
---|---|
528201 |
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Hurst, R., et al. 2005. J. Neurosci. 25, 4396. Barron, S., et al. 2009. Mol. Pharm. 76, 253. |